EXEL

Exelixis, Inc. News Headlines

$3.29
*  
0.03
 negative 
0.9%
Get EXEL Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Pre-Market Most Active for Nov 1, 2013 : T, ABX, FB, CTL, AIG, PCAR, HOT, ALU, WDC, FSLR, EXEL, MDLZ
11/1/2013 8:39:57 AM - NASDAQ.com News

After Hours Most Active for Oct 30, 2013 : FB, PBR/A, BEN, QQQ, EXPE, MCP, BAC, MNKD, CSCO, EXEL, AA, HCA
10/30/2013 4:42:50 PM - NASDAQ.com News

Pre-Market Most Active for Oct 30, 2013 : TEVA, S, WU, GM, NOK, HCA, FB, ARIA, BIDU, EXEL, MACK, SODA
10/30/2013 8:39:56 AM - NASDAQ.com News

After Hours Most Active for Oct 29, 2013 : ATVI, NOK, T, QQQ, RAD, RENN, FB, TTWO, YELP, TIBX, LNKD, EXEL
10/29/2013 4:45:03 PM - NASDAQ.com News

Interview With Cowen's Dr. Eric Schmidt: These 2 Biotech Stocks Could Outperform
10/16/2013 11:45:00 AM - Seeking Alpha

Biotech Stocks Continue Recent Downtrend; Ariad Tumbles to Lowest Price in Nearly Three Years
10/9/2013 12:40:01 PM - MT Newswires

Exelixis: Promise In The Pipeline
9/30/2013 10:39:00 AM - Seeking Alpha

Healthcare Stocks Higher Near Close; Exelixis Climbs to New 52-Week High After Starting Liver-Cancer Drug Trial
9/10/2013 3:57:36 PM - MT Newswires

Sector Update: Healthcare
9/10/2013 3:55:00 PM - MT Newswires

Trade the Earnings: Exelixis, Inc.
8/6/2013 6:41:22 AM - MT Newswires

Cramer's Lightning Round - Tesla Remains A Cult Stock (7/16/13)
7/17/2013 6:19:00 AM - Seeking Alpha

Exelixis And Cabozantinib: ASCO 2013 Highlights
6/7/2013 11:47:00 AM - Seeking Alpha

3 Innovative Biotech Companies With Promising Cancer Therapies
5/29/2013 11:38:00 AM - Seeking Alpha

Exelixis Prepares For ASCO 2013, Stock Stays Rangebound
5/24/2013 3:23:00 PM - Seeking Alpha

Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
5/12/2013 6:06:00 PM - Seeking Alpha

Cramer's Lightning Round- Kicking Myself Over Toll Brothers (4/16/13)
4/17/2013 7:05:00 AM - Seeking Alpha

Solving The R&D Investment Dilemma With Project Funding: Mark Kessel
3/24/2013 4:30:00 AM - Seeking Alpha

4 Biotech Stocks On The Clock
2/19/2013 9:44:00 AM - Seeking Alpha

Revisiting Exelixis And Cabozantinib
1/30/2013 4:56:00 PM - Seeking Alpha

Pipeline Advances at Exelixis - Analyst Blog
1/18/2013 7:05:01 PM - Zacks.com

3 Highly Shorted Stocks Under $5 Being Snapped By Hedge Funds
1/15/2013 5:04:00 AM - Seeking Alpha

Biotech Portfolio Update: 2012 Summary And 2013 Outlook
12/24/2012 7:24:00 AM - Seeking Alpha

5 Medical Stock Losers From Last Week With High Short Ratios
12/22/2012 6:23:00 AM - Seeking Alpha

Exelixis Rebounds From 'Sell The News' Reaction
12/17/2012 10:58:00 AM - Seeking Alpha

Aveo Pharmaceuticals: A Hidden Gem Or A Hidden Disaster
12/10/2012 11:20:00 AM - Seeking Alpha